Considering the connections (Supplementary Figure S3) between NRXN1 and TP53, through our WNT-relating pathway network, the effect of the NRXN1 mutations needs to be measured in WNT signaling, possibly linking to other signaling subnetworks that underlie the two cancer hallmark phenotypes. This evidence concerns the gene TP53 and cancer.